Sign in Pull a receipt

SCYX

SCYNEXIS INC

Healthcare · Drug Manufacturers - Specialty & Generic

$59.90 sample

-0.50 (-0.83%) 1D

Market cap

$332.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-20

Alerts

8

Price$59.90 +4.37% 3M daily closessample

60.4554.77

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider buy: EVP, Operations
Oct 20SEC8-K filed: material event
Oct 13SECForm 144 filed
Oct 08INSInsider sell: Chief Executive Officer
Oct 02SECDEF 14A filed
Sep 23INSInsider buy: EVP, Operations
Sep 16INSInsider buy: Director
Sep 09SECForm 144 filed

Sign up to see the real SCYX record →

Company facts

SEC EDGAR registration

Name: SCYNEXIS INC
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -56sample, -100 to +100
Reporting currency: USD

Who is positioning in SCYX

sample

Insiders: 27 insider transactions over 90 days, net selling, $308.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 30 funds hold $7.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.0B +21.3% y/y

Q4 2024Q3 2026

Inventory$6.9B +7.9% y/y

Q4 2024Q3 2026

Accounts receivable$5.0B +7.8% y/y

Q4 2024Q3 2026

Total debt$13.7B +6.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $68.7B +8.3% 3M
Sample peer B: $224.5B +9.0% 3M
Sample peer C: $222.4B +2.9% 3M
Sample peer D: $222.7B -11.9% 3M
Sample peer E: $108.9B -8.5% 3M